Company registration number SC750552 (Scotland)
GLASGOW WOMEN'S HEALTH CLINIC LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
GLASGOW WOMEN'S HEALTH CLINIC LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
GLASGOW WOMEN'S HEALTH CLINIC LTD
BALANCE SHEET
AS AT 30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Cash at bank and in hand
115
607
Creditors: amounts falling due within one year
3
(9,013)
(507)
Net current (liabilities)/assets
(8,898)
100
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(8,998)
-
0
Total equity
(8,898)
100

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 June 2026 and are signed on its behalf by:
Ms Anna Rex
Director
Company registration number SC750552 (Scotland)
GLASGOW WOMEN'S HEALTH CLINIC LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information

Glasgow Women's Health Clinic Ltd is a private company limited by shares incorporated in Scotland. The registered office is 6th Floor, Gordon Chambers, 90 Mitchell Street, Glasgow, Scotland, G1 3NQ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future. The company's liabilities exceed its assets by £8,898 at 30 November 2025 (2024 - assets exceed liabilities by £100).true

 

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
0
3
Creditors: amounts falling due within one year
2025
2024
£
£
Other creditors
8,449
507
Accruals and deferred income
564
-
0
9,013
507
2025-11-302024-12-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100No description of principal activityMs Maeve MacleodMs Anna RexSC7505522024-12-012025-11-30SC7505522025-11-30SC7505522024-11-30SC750552core:CurrentFinancialInstrumentscore:WithinOneYear2025-11-30SC750552core:CurrentFinancialInstrumentscore:WithinOneYear2024-11-30SC750552core:ShareCapital2025-11-30SC750552core:ShareCapital2024-11-30SC750552core:RetainedEarningsAccumulatedLosses2025-11-30SC750552core:RetainedEarningsAccumulatedLosses2024-11-30SC750552bus:Director22024-12-012025-11-30SC7505522023-12-012024-11-30SC750552bus:PrivateLimitedCompanyLtd2024-12-012025-11-30SC750552bus:SmallCompaniesRegimeForAccounts2024-12-012025-11-30SC750552bus:FRS1022024-12-012025-11-30SC750552bus:AuditExempt-NoAccountantsReport2024-12-012025-11-30SC750552bus:Director12024-12-012025-11-30SC750552bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP